Back to Authors

Shanmuganathan, Naranie

0000-0001-5895-8797

A5039876833 | I1320133117

Mayo Clinic

Royal Adelaide Hospital

Citations 4

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

Blood | December 27, 2022 | Volume: 141 | Issue: 9 | Pages: 1087-1091

10.1182/blood.2022018236 | PMID 36574363

TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799

10.1182/blood-2022-165859

Personalized Prediction Model to Risk Stratify Patients with Therapy-Related Myeloid Neoplasms

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6962-6963

10.1182/blood-2022-167978

Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6964-6965

10.1182/blood-2022-168349